Starter FHIR Implementation Guide
1.0.1 - ci-build
Starter FHIR Implementation Guide, published by Jembi Health Systems. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/jembi/Starter-FHIR-IG/ and changes regularly. See the Directory of published versions
| Official URL: http://jembi.org/fhir/ValueSet/arv-treatment-value-set | Version: 1.0.1 | |||
| Active as of 2025-09-26 | Computable Name: ARVTreatmentValueSet | |||
A list of codes describing the ARV Drugs.
References
http://loinc.org| Code | Display |
| LP21306-3 | Abacavir |
| LP14522-4 | Acyclovir |
| LP28549-1 | Adefovir |
| LP14353-4 | Amantadine |
| LP21307-1 | Amprenavir |
| LP64721-1 | Amprenavir or Fosamprenavir |
| LP31472-1 | Antiretroviral/Anti-HIV |
| LP35785-2 | Atazanavir |
| LP64715-3 | Atazanavir+Ritonavir |
| LP268150-2 | Bictegravir |
| LP157328-8 | Boceprevir |
| LP420400-6 | Cabotegravir |
| LP30899-6 | Cidofovir |
| LP220247-3 | Daclatasvir |
| LP64724-5 | Darunavir |
| LP64726-0 | Darunavir+Ritonavir |
| LP21173-7 | Delavirdine |
| LP21309-7 | Didanosine |
| LP157327-0 | Dolutegravir |
| LP310284-7 | Doravirine |
| LP21310-5 | Efavirenz |
| LP220248-1 | Elbasvir |
| LP157318-9 | Elvitegravir |
| LP35786-0 | Emtricitabine |
| LP157324-7 | Enfuvirtide |
| LP96213-1 | Entecavir |
| LP68431-3 | Etravirine |
| LP157326-2 | Famciclovir |
| LP36119-3 | Fosamprenavir |
| LP15741-9 | Ganciclovir |
| LP343292-1 | Glecaprevir |
| LP21311-3 | Indinavir |
| LP64716-1 | Indinavir+Ritonavir |
| LP220249-9 | Ledipasvir |
| LP28756-2 | Lopinavir |
| LP266720-4 | Maraviroc |
| LP157325-4 | Maribavir |
| LP21313-9 | Nelfinavir |
| LP21317-0 | Nevirapine |
| LP220250-7 | Ombitasvir |
| LP35840-5 | Oritavancin |
| LP101308-7 | Oseltamivir |
| LP101310-3 | Oseltamivir+Zanamivir |
| LP101038-0 | Penciclovir |
| LP343295-4 | Pibrentasvir |
| LP102418-3 | Raltegravir |
| LP35809-0 | Ribavirin |
| LP21314-7 | Ritonavir |
| LP14466-4 | Saquinavir |
| LP64718-7 | Saquinavir+Ritonavir |
| LP220265-5 | Sofosbuvir |
| LP21315-4 | Stavudine |
| LP157329-6 | Telaprevir |
| LP96214-9 | Telbivudine |
| LP28761-2 | Tenofovir |
| LP36120-1 | Tipranavir |
| LP64719-5 | Tipranavir+Ritonavir |
| LP343299-6 | Voxilaprevir |
| LP21316-2 | Zalcitabine |
| LP101309-5 | Zanamivir |
| LP16744-2 | Zidovudine |
| LP21312-1 | lamiVUDine |
| LP64717-9 | lamiVUDine or Emtricitabine |
| LP157730-5 | valGANciclovir |
Expansion from tx.fhir.org based on Loinc v2.81
This value set contains 64 concepts
| Code | System | Display |
| LP21306-3 | http://loinc.org | Abacavir |
| LP14522-4 | http://loinc.org | Acyclovir |
| LP28549-1 | http://loinc.org | Adefovir |
| LP14353-4 | http://loinc.org | Amantadine |
| LP21307-1 | http://loinc.org | Amprenavir |
| LP64721-1 | http://loinc.org | Amprenavir or Fosamprenavir |
| LP31472-1 | http://loinc.org | Antiretroviral/Anti-HIV |
| LP35785-2 | http://loinc.org | Atazanavir |
| LP64715-3 | http://loinc.org | Atazanavir+Ritonavir |
| LP268150-2 | http://loinc.org | Bictegravir |
| LP157328-8 | http://loinc.org | Boceprevir |
| LP420400-6 | http://loinc.org | Cabotegravir |
| LP30899-6 | http://loinc.org | Cidofovir |
| LP220247-3 | http://loinc.org | Daclatasvir |
| LP64724-5 | http://loinc.org | Darunavir |
| LP64726-0 | http://loinc.org | Darunavir+Ritonavir |
| LP21173-7 | http://loinc.org | Delavirdine |
| LP21309-7 | http://loinc.org | Didanosine |
| LP157327-0 | http://loinc.org | Dolutegravir |
| LP310284-7 | http://loinc.org | Doravirine |
| LP21310-5 | http://loinc.org | Efavirenz |
| LP220248-1 | http://loinc.org | Elbasvir |
| LP157318-9 | http://loinc.org | Elvitegravir |
| LP35786-0 | http://loinc.org | Emtricitabine |
| LP157324-7 | http://loinc.org | Enfuvirtide |
| LP96213-1 | http://loinc.org | Entecavir |
| LP68431-3 | http://loinc.org | Etravirine |
| LP157326-2 | http://loinc.org | Famciclovir |
| LP36119-3 | http://loinc.org | Fosamprenavir |
| LP15741-9 | http://loinc.org | Ganciclovir |
| LP343292-1 | http://loinc.org | Glecaprevir |
| LP21311-3 | http://loinc.org | Indinavir |
| LP64716-1 | http://loinc.org | Indinavir+Ritonavir |
| LP220249-9 | http://loinc.org | Ledipasvir |
| LP28756-2 | http://loinc.org | Lopinavir |
| LP266720-4 | http://loinc.org | Maraviroc |
| LP157325-4 | http://loinc.org | Maribavir |
| LP21313-9 | http://loinc.org | Nelfinavir |
| LP21317-0 | http://loinc.org | Nevirapine |
| LP220250-7 | http://loinc.org | Ombitasvir |
| LP35840-5 | http://loinc.org | Oritavancin |
| LP101308-7 | http://loinc.org | Oseltamivir |
| LP101310-3 | http://loinc.org | Oseltamivir+Zanamivir |
| LP101038-0 | http://loinc.org | Penciclovir |
| LP343295-4 | http://loinc.org | Pibrentasvir |
| LP102418-3 | http://loinc.org | Raltegravir |
| LP35809-0 | http://loinc.org | Ribavirin |
| LP21314-7 | http://loinc.org | Ritonavir |
| LP14466-4 | http://loinc.org | Saquinavir |
| LP64718-7 | http://loinc.org | Saquinavir+Ritonavir |
| LP220265-5 | http://loinc.org | Sofosbuvir |
| LP21315-4 | http://loinc.org | Stavudine |
| LP157329-6 | http://loinc.org | Telaprevir |
| LP96214-9 | http://loinc.org | Telbivudine |
| LP28761-2 | http://loinc.org | Tenofovir |
| LP36120-1 | http://loinc.org | Tipranavir |
| LP64719-5 | http://loinc.org | Tipranavir+Ritonavir |
| LP343299-6 | http://loinc.org | Voxilaprevir |
| LP21316-2 | http://loinc.org | Zalcitabine |
| LP101309-5 | http://loinc.org | Zanamivir |
| LP16744-2 | http://loinc.org | Zidovudine |
| LP21312-1 | http://loinc.org | lamiVUDine |
| LP64717-9 | http://loinc.org | lamiVUDine or Emtricitabine |
| LP157730-5 | http://loinc.org | valGANciclovir |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |